Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jiabing Wang

Showing results (41-50 of 62) with videos related to

Pageof 7
Sort By:
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|March 27, 2024
Withaferin A, a natural thioredoxin reductase 1 (TrxR1) inhibitor, synergistically enhances the antitumor efficacy of sorafenib through ROS-mediated ER stress and DNA damage in hepatocellular carcinoma cellsXi Chen, Ning Zhu, Yajie Wu, et al.
Journal of Medicinal Chemistry|August 28, 2015
Discovery and Evaluation of Clinical Candidate AZD3759, a Potent, Oral Active, Central Nervous System-Penetrant, Epidermal Growth Factor Receptor Tyrosine Kinase InhibitorQingbei Zeng, Jiabing Wang, Ziqiang Cheng, et al.
Stem Cell Research & Therapy|March 5, 2026
The efficacy and safety of MSCs in GVHD prevention and the treatment of SR-aGVHD: a systematic review and meta-analysis of randomized controlled trialsShuzhou Wu, Wenming Lu, An Xie, et al.
Bioorganic & Medicinal Chemistry Letters|February 28, 2017
Novel antioxidants' synthesis and their anti-oxidative activity through activating Nrf2 signaling pathwayJianzhang Wu, Jiye Ren, Song Yao, et al.
Acta Pharmaceutica Sinica. B|August 15, 2022
Erratum: Author correction to 'Design, synthesis and biological evaluation of chalcone analogues with novel dual antioxidant mechanisms as potential anti-ischemic stroke agents' [Acta Pharmaceutica Sinica B 9 (2019) 335-350]Jiabing Wang, Lili Huang, Chanchan Chen, et al.
Acta Pharmaceutica Sinica. B|April 12, 2019
Design, synthesis and biological evaluation of chalcone analogues with novel dual antioxidant mechanisms as potential anti-ischemic stroke agentsJiabing Wang, Lili Huang, Chanchan Cheng, et al.
Chemico-Biological Interactions|October 12, 2025
Targeting thioredoxin reductase 1 by Andrographolide contributes to inducing ROS-mediated apoptosis in human NSCLC cellsJiabing Wang, Kaiwen Jin, Nan Jin, et al.
Biomed Research International|February 16, 2018
Corrigendum to "Curcumin Analogue CA15 Exhibits Anticancer Effects on HEp-2 Cells via Targeting NF-<i>κ</i>B"Jian Chen, Linlin Zhang, Yilai Shu, et al.
Biomed Research International|April 15, 2017
Curcumin Analogue CA15 Exhibits Anticancer Effects on HEp-2 Cells via Targeting NF-<i>κ</i>BJian Chen, Linlin Zhang, Yilai Shu, et al.
European Journal of Medicinal Chemistry|November 26, 2016
Design, synthesis, and evaluation of asymmetric EF24 analogues as potential anti-cancer agents for lung cancerJianzhang Wu, Shoubiao Wu, Lingyi Shi, et al.
Pageof 7

Showing results (41-50 of 62) with videos related to

Sort By:
Pageof 7
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|March 27, 2024
Withaferin A, a natural thioredoxin reductase 1 (TrxR1) inhibitor, synergistically enhances the antitumor efficacy of sorafenib through ROS-mediated ER stress and DNA damage in hepatocellular carcinoma cellsXi Chen, Ning Zhu, Yajie Wu, et al.
Journal of Medicinal Chemistry|August 28, 2015
Discovery and Evaluation of Clinical Candidate AZD3759, a Potent, Oral Active, Central Nervous System-Penetrant, Epidermal Growth Factor Receptor Tyrosine Kinase InhibitorQingbei Zeng, Jiabing Wang, Ziqiang Cheng, et al.
Stem Cell Research & Therapy|March 5, 2026
The efficacy and safety of MSCs in GVHD prevention and the treatment of SR-aGVHD: a systematic review and meta-analysis of randomized controlled trialsShuzhou Wu, Wenming Lu, An Xie, et al.
Bioorganic & Medicinal Chemistry Letters|February 28, 2017
Novel antioxidants' synthesis and their anti-oxidative activity through activating Nrf2 signaling pathwayJianzhang Wu, Jiye Ren, Song Yao, et al.
Acta Pharmaceutica Sinica. B|August 15, 2022
Erratum: Author correction to 'Design, synthesis and biological evaluation of chalcone analogues with novel dual antioxidant mechanisms as potential anti-ischemic stroke agents' [Acta Pharmaceutica Sinica B 9 (2019) 335-350]Jiabing Wang, Lili Huang, Chanchan Chen, et al.
Acta Pharmaceutica Sinica. B|April 12, 2019
Design, synthesis and biological evaluation of chalcone analogues with novel dual antioxidant mechanisms as potential anti-ischemic stroke agentsJiabing Wang, Lili Huang, Chanchan Cheng, et al.
Chemico-Biological Interactions|October 12, 2025
Targeting thioredoxin reductase 1 by Andrographolide contributes to inducing ROS-mediated apoptosis in human NSCLC cellsJiabing Wang, Kaiwen Jin, Nan Jin, et al.
Biomed Research International|February 16, 2018
Corrigendum to "Curcumin Analogue CA15 Exhibits Anticancer Effects on HEp-2 Cells via Targeting NF-<i>κ</i>B"Jian Chen, Linlin Zhang, Yilai Shu, et al.
Biomed Research International|April 15, 2017
Curcumin Analogue CA15 Exhibits Anticancer Effects on HEp-2 Cells via Targeting NF-<i>κ</i>BJian Chen, Linlin Zhang, Yilai Shu, et al.
European Journal of Medicinal Chemistry|November 26, 2016
Design, synthesis, and evaluation of asymmetric EF24 analogues as potential anti-cancer agents for lung cancerJianzhang Wu, Shoubiao Wu, Lingyi Shi, et al.
Pageof 7